Pharma Pulse 9/17/24: mHealth and Home Monitoring Report, Increasing Access to Legitimate Weight Loss Medications & more

Increasing Access to Legitimate Weight Loss Medications

In this part of their Pharmaceutical Executive video interview, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss how UpScriptHealth is working to increase access to legitimate weight loss medications, especially for those in underserved communities.

FDA Warns of Liver Injury with Veozah for Hot Flashes

The FDA has identified a probable case of serious drug induced liver injury that occurred in a woman in the United States who had received Veozah. The agency is requiring additional liver blood testing after starting therapy.

Roche Shares Slump on Oral Weight-Loss Drug Candidate Side Effects

The company said the drug was generally well tolerated, but some patients showed gastrointestinal side effects that were consistent with similar drugs at an early stage of development.

mHealth and Home Monitoring Report, 2024

The number of connected home medical monitoring devices on the global market was 76.7 million at the end of 2023 and is forecasted to grow at a CAGR of 12.8 percent in the next five years to reach 140.1 million in 2028.

The adoption of mHealth solutions in healthcare is driven by a wide range of incentives, related to everything from demographics and technology development to new advancements in medical treatment. The primary focus of this report is on home monitoring solutions, which are commonly used to manage patients with various chronic conditions such as cardiac arrhythmia, sleep apnoea and diabetes. Other applications include remote diagnostics, compliance monitoring and clinical trials.

Yago Llaquet on LinkedIn

Very inspiring article Cristina Ortega Duran. I couldn't agree more—understanding key pain points and co-creating solutions with patients are crucial for ensuring success and global scalability. A diverse team and new WoW are essential enablers for driving meaningful innovation 👏 👏 👏

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs